Unknown PHASE4 INTERVENTIONAL NCT00288535

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions

Sponsor: Cordis, Johnson&Johnson company

Conditions Coronary Artery Disease

Interventions PCI of bifurcated coronary lesions using sirolimus coated stents in modified T-Stenting -Technique

Updated 6 times since 2017 Last updated: Sep 17, 2007 Started: Mar 31, 2005 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease, this trial is ongoing. The trial is conducted by Cordis, Johnson&Johnson company and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Dec 2019 — Jan 2021 [monthly]

Unknown Status PHASE4
Jun 2018 — Dec 2019 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cordis, Johnson&Johnson company
University Heart Center Freiburg - Bad Krozingen

Data source: University Heart Center Freiburg - Bad Krozingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bad Krozingen, Germany